申请人:Merck Sharp & Dohme Corp.
公开号:US20160207926A1
公开(公告)日:2016-07-21
The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflamation, asthma, COPD and cancer.
本发明提供了I式化合物,它们是PI3K-delta抑制剂,因此可用于治疗PI3K-delta介导的疾病,如炎症、哮喘、COPD和癌症。